The COVID-19 pandemic led to three years(2020-2022)of human activity restrictions in China,significantly impacting urban air quality,yet long-term health risks from PM2.5-bound heavy metals remain unclear.This stud...The COVID-19 pandemic led to three years(2020-2022)of human activity restrictions in China,significantly impacting urban air quality,yet long-term health risks from PM2.5-bound heavy metals remain unclear.This study observed PM2.5 and 21 associated metals in Shenzhen over six years(2017-2022),aiming to identify sources,assess their health impacts,and explore COVID-19 effects on health risks.The total carcinogenic risk(CR)of 5 metals decreased by 23%during the pandemic(2020-2022)compared to pre-pandemic levels(2017-2019),similar to the trends of PM2.5 and total metals concentrations.In contrast,the non-carcinogenic risk(NCR)of 11 metals increased by 20%,primarily due to the rise in manganese(Mn)concentration caused by vehicle emissions,but NCR still below the risk threshold.Vehicle emissions were the main contributor to NCR(68%)and CR(55%).Machine learning revealed that the source emissions reduction is the primary factor contributing to the decline in the CR of metals bound to PM2.5,except for the increased health risk associated with vehicles.During the pandemic,the slowed growth rate of CR of vehicle emissions and the significant decline in CR of fugitive dust demonstrated the effectiveness of pandemic-induced traffic and production restrictions in reducing anthropogenic emissions and mitigating PM2.5-bound heavy metal health risks in Shenzhen.However,total CR of heavy metals in 2022 exceeded the acceptable risk threshold(1×10-6),emphasizing the ongoing challenge of regulating PM2.5 and the need to prioritize vehicle emission management.展开更多
Danhong injection (DHI), a Chinese Materia Medica standardized product extracted from Radix Salviae miltiorrhizae and Flos Carthami tinctorii, is widely used in China for treating acute isch-emic stroke. In the pres...Danhong injection (DHI), a Chinese Materia Medica standardized product extracted from Radix Salviae miltiorrhizae and Flos Carthami tinctorii, is widely used in China for treating acute isch-emic stroke. In the present study, we explored the neuroprotective efficacy of DHI in a rat model of temporary middle cerebral artery ocdusion, and evaluated the potential mechanisms under-lying its effects. Pretreatment with DHI (0.9 and 1.8 mL/kg) resulted in a significantly smaller infarct volume and better neurological scores than pretreatment with saline. Furthermore, DHI significantly reduced the permeability of the blood-brain barrier, increased occludin protein expression and decreased neutrophil infiltration, as well as profoundly suppressing the upreg-ulation of matrix metallopeptidase-9 expression seen in rats that had received vehicle. Matrix metallopeptidase-2 expression was not affected by ischemia or DHI. Moreover, DHI (1.8 mL/kg) administered 3 hours after the onset of ischemia also improved neurological scores and reduced infarct size. Our results indicate that the neuroprotective efficacy of DHI in a rat model of cerebral ischemia-reperfusion injury is mediated by a protective effect on the blood-brain barrier and the reversal of neutrophil infiltration.展开更多
The present study monitored the effect of 2, 10, and 50 mg/L of Panax notoginseng saponin exposure following hypoxia-reoxygenation injury in fetal rat cortical neurons. Results showed that varying doses of Panax notog...The present study monitored the effect of 2, 10, and 50 mg/L of Panax notoginseng saponin exposure following hypoxia-reoxygenation injury in fetal rat cortical neurons. Results showed that varying doses of Panax notoginseng saponin significantly enhanced the cell viability of neurons, reduced malondialdehyde content, increased superoxide dismutase activity, inhibited mRNA and protein expression of inducible and neuronal nitric oxide synthase, and decreased the release of nitric oxide in hypoxiaeoxygenation injured cells. In particular, 50 mg/L of Panax notoginseng saponin was the most effective dose. These findings suggest that Panax notoginseng saponin can attenuate neuronal oxidative stress injury caused by hypoxiaeoxygenation in a dose-dependent manner.展开更多
Stroke is the third leading cause of death and the first cause of adult disability in industrial countries [1]. It is charicaterized by hemiplegia, hemianopsia, aphasia, mouth askew and sever sequelae. It is considere...Stroke is the third leading cause of death and the first cause of adult disability in industrial countries [1]. It is charicaterized by hemiplegia, hemianopsia, aphasia, mouth askew and sever sequelae. It is considered that an ischemic disease without any specific treatment method and few effective drugs such as tPA (human tissue-type plasminogen activator) and Edarovone with specific therapeutic window will cause a lot of disadvantages if being used inaccurate. Root of Panax notoginseng (PN) which is one of traditional Chinese medicines (TCMs), was first found in “Shennong’s Classic of Materia Medica” around 200 AD. Panax notogineng saponins(PNS) is a multi-components mixture containing ginseng and saponins as the most important bioactive components which are commonly used in clinical treatment. Also, ginseng and saponins form the main components of many herbal medicines in the market, e.g., Xueshuantong injection [2], Xuesaitong injection [3], Xuesaitong soft capsule [4] and so on. The main monomers of Panax notoginseng saponins (PNS) are Ginsenoside-Rb1, Gensenoside-Rg1, Gensenoside-Re, Gensenoside-Rd and Panax notoginseng saponins-R1 [5]. In this review, we found some important points as well as shortcomings that require special consideration. We therefore highlighted the advances in neuro-protection of PNS and its main monomers in the area of experimental research.展开更多
基金supported by the National Key Research and Development Program of China(No.2023YFC3709203)the National Natural Science Foundation of China(No.42407132)。
摘要The COVID-19 pandemic led to three years(2020-2022)of human activity restrictions in China,significantly impacting urban air quality,yet long-term health risks from PM2.5-bound heavy metals remain unclear.This study observed PM2.5 and 21 associated metals in Shenzhen over six years(2017-2022),aiming to identify sources,assess their health impacts,and explore COVID-19 effects on health risks.The total carcinogenic risk(CR)of 5 metals decreased by 23%during the pandemic(2020-2022)compared to pre-pandemic levels(2017-2019),similar to the trends of PM2.5 and total metals concentrations.In contrast,the non-carcinogenic risk(NCR)of 11 metals increased by 20%,primarily due to the rise in manganese(Mn)concentration caused by vehicle emissions,but NCR still below the risk threshold.Vehicle emissions were the main contributor to NCR(68%)and CR(55%).Machine learning revealed that the source emissions reduction is the primary factor contributing to the decline in the CR of metals bound to PM2.5,except for the increased health risk associated with vehicles.During the pandemic,the slowed growth rate of CR of vehicle emissions and the significant decline in CR of fugitive dust demonstrated the effectiveness of pandemic-induced traffic and production restrictions in reducing anthropogenic emissions and mitigating PM2.5-bound heavy metal health risks in Shenzhen.However,total CR of heavy metals in 2022 exceeded the acceptable risk threshold(1×10-6),emphasizing the ongoing challenge of regulating PM2.5 and the need to prioritize vehicle emission management.
基金supported by the National Natural Science Foundation of China,No.81173592National Science and Technology Major Project of the Ministry of Science and Technology of China,No.2011ZX09201-201,2012ZX09101201-004,2012ZX09101202,NCET-130935,2013ZX09201020+1 种基金Tianjin Municipal Applied Basic Research and Cutting-Edge Technology Research Scheme of China,No.14JCYBJC28900Program for Innovation Team Training in Universities in Tianjin,No.TD12-5035
摘要Danhong injection (DHI), a Chinese Materia Medica standardized product extracted from Radix Salviae miltiorrhizae and Flos Carthami tinctorii, is widely used in China for treating acute isch-emic stroke. In the present study, we explored the neuroprotective efficacy of DHI in a rat model of temporary middle cerebral artery ocdusion, and evaluated the potential mechanisms under-lying its effects. Pretreatment with DHI (0.9 and 1.8 mL/kg) resulted in a significantly smaller infarct volume and better neurological scores than pretreatment with saline. Furthermore, DHI significantly reduced the permeability of the blood-brain barrier, increased occludin protein expression and decreased neutrophil infiltration, as well as profoundly suppressing the upreg-ulation of matrix metallopeptidase-9 expression seen in rats that had received vehicle. Matrix metallopeptidase-2 expression was not affected by ischemia or DHI. Moreover, DHI (1.8 mL/kg) administered 3 hours after the onset of ischemia also improved neurological scores and reduced infarct size. Our results indicate that the neuroprotective efficacy of DHI in a rat model of cerebral ischemia-reperfusion injury is mediated by a protective effect on the blood-brain barrier and the reversal of neutrophil infiltration.
基金supported by the National Basic Research Program of China (973 Program),No.2005CB523404the National Natural Science Foundation, No.30901922Science and Technology Development Fund forUniversities in Tianjin,No.2006305
摘要The present study monitored the effect of 2, 10, and 50 mg/L of Panax notoginseng saponin exposure following hypoxia-reoxygenation injury in fetal rat cortical neurons. Results showed that varying doses of Panax notoginseng saponin significantly enhanced the cell viability of neurons, reduced malondialdehyde content, increased superoxide dismutase activity, inhibited mRNA and protein expression of inducible and neuronal nitric oxide synthase, and decreased the release of nitric oxide in hypoxiaeoxygenation injured cells. In particular, 50 mg/L of Panax notoginseng saponin was the most effective dose. These findings suggest that Panax notoginseng saponin can attenuate neuronal oxidative stress injury caused by hypoxiaeoxygenation in a dose-dependent manner.
摘要Stroke is the third leading cause of death and the first cause of adult disability in industrial countries [1]. It is charicaterized by hemiplegia, hemianopsia, aphasia, mouth askew and sever sequelae. It is considered that an ischemic disease without any specific treatment method and few effective drugs such as tPA (human tissue-type plasminogen activator) and Edarovone with specific therapeutic window will cause a lot of disadvantages if being used inaccurate. Root of Panax notoginseng (PN) which is one of traditional Chinese medicines (TCMs), was first found in “Shennong’s Classic of Materia Medica” around 200 AD. Panax notogineng saponins(PNS) is a multi-components mixture containing ginseng and saponins as the most important bioactive components which are commonly used in clinical treatment. Also, ginseng and saponins form the main components of many herbal medicines in the market, e.g., Xueshuantong injection [2], Xuesaitong injection [3], Xuesaitong soft capsule [4] and so on. The main monomers of Panax notoginseng saponins (PNS) are Ginsenoside-Rb1, Gensenoside-Rg1, Gensenoside-Re, Gensenoside-Rd and Panax notoginseng saponins-R1 [5]. In this review, we found some important points as well as shortcomings that require special consideration. We therefore highlighted the advances in neuro-protection of PNS and its main monomers in the area of experimental research.